For example, CD4 and CD8 antigen-specific T cell responses were produced after vaccination with mRNA vaccines in a small group of MS patients treated with anti-CD20, with impaired circulating follicular helper T cell responses and enhanced CD8 T cell responses (29). The gene discussed is CD8A; the disease is myeloid sarcoma.